We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFBK
526
DELISTED
Northfield Bancorp
NFBK
| $2.82M | 0.01% |
214,844
+147,119
| +217% | +$1.9M |
|
527
LiveRamp
RAMP
$2.3B
| $2.77M | 0.01% |
127,521
-154,139
| -55% | -$3.97M |
|
|
AUXL
528
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $2.71M | 0.01% |
+135,143
| New | +$3.1M |
|
529
Amdocs
DOX
$6.28B
| $2.71M | 0.01% |
+58,466
| New | +$2.75M |
|
|
CQB
530
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $2.71M | 0.01% |
249,586
-259,378
| -51% | -$2.89M |
|
|
PES
531
DELISTED
Pioneer Energy Services Corp.
PES
| $2.7M | 0.01% |
153,880
+129,665
| +535% | +$1.94M |
|
532
Harmonic Inc
HLIT
$1.27B
| $2.69M | 0.01% |
360,048
-430,293
| -54% | -$3.1M |
|
|
LMNX
533
DELISTED
Luminex Corp
LMNX
| $2.66M | 0.01% |
154,869
+41,041
| +36% | +$722K |
|
|
EQC
534
DELISTED
Equity Commonwealth
EQC
| $2.65M | 0.01% |
+100,690
| New | +$2.65M |
|
|
ININ
535
DELISTED
Interactive Intelligence Group, inc.
ININ
| $2.63M | 0.01% |
46,829
+1,258
| +3% | +$72K |
|
536
Safe Bulkers
SB
$781M
| $2.63M | 0.01% |
268,981
+86,260
| +47% | +$750K |
|
|
SFY
537
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
| $2.56M | 0.01% |
196,852
+87,593
| +80% | +$998K |
|
538
Choice Hotels
CHH
$4.94B
| $2.49M | 0.01% |
+52,948
| New | +$2.39M |
|
539
iShares MSCI Japan ETF
EWJ
$22.5B
| $2.48M | 0.01% |
51,464
-7,412
| -13% | -$339K |
|
|
LPT
540
DELISTED
Liberty Property Trust
LPT
| $2.47M | 0.01% |
+65,185
| New | +$2.47M |
|
541
Comtech Telecommunications
CMTL
$51.5M
| $2.44M | 0.01% |
65,485
+23,152
| +55% | +$777K |
|
542
Molson Coors Class B
TAP
$7.92B
| $2.44M | 0.01% |
32,933
-15,263
| -32% | -$983K |
|
543
Costamare
CMRE
$1.8B
| $2.44M | 0.01% |
104,608
+71,514
| +216% | +$1.56M |
|
|
MSCC
544
DELISTED
Microsemi Corp
MSCC
| $2.4M | 0.01% |
89,668
+76,313
| +571% | +$1.9M |
|
545
Biglari Holdings Class B
BH
$1.22B
| $2.4M | 0.01% |
9,155
-3,439
| -27% | -$925K |
|
|
TWX
546
DELISTED
Time Warner Inc
TWX
| $2.38M | 0.01% |
+33,907
| New | +$2.23M |
|
|
IPHI
547
DELISTED
INPHI CORPORATION
IPHI
| $2.38M | 0.01% |
161,906
+33,395
| +26% | +$502K |
|
548
Marten Transport
MRTN
$1.21B
| $2.35M | 0.01% |
263,325
-33,588
| -11% | -$306K |
|
549
Pacira BioSciences
PCRX
$1.02B
| $2.35M | 0.01% |
+25,586
| New | +$1.95M |
|
550
Greif
GEF
$5.07B
| $2.34M | 0.01% |
42,932
+19,493
| +83% | +$1.05M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.